Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

Daily Archives: December 17, 2018

Top 20 Shareholders 14 December 2018

News & Announcements 2018By Richard Mollard December 17, 2018

Top_Holders_Report (14)Download

Recent Articles

April 30, Top 20 Shareholders
May 1, 2021
April 29, Appendix 4C and Quarterly Update
April 29, 2021
April 27, Monepantel Phase IIb Dog Lymphoma Interim Plasma Data
April 27, 2021
April 8, PharmAust Receives $750k R&D Tax Incentive Refund
April 8, 2021

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

PharmAust @PharmAust·

PharmAust calls on experienced exec in push to commercialise its drug for canine cancer

https://stockhead.com.au/health/pharmaust-calls-on-experienced-exec-in-push-to-commercialise-its-drug-for-canine-cancer/

Reply on Twitter 1393043536568668167 Retweet on Twitter 13930435365686681672 Like on Twitter 13930435365686681675 Twitter 1393043536568668167

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions